EMA Issues Guidance on Development of Flu Vaccines

Drug Industry Daily
A A
Developers of influenza vaccines in Europe will have to conduct additional postmarket effectiveness studies and expand their criteria for evaluating immune responses of products in the clinical testing phase, according to the European Medicines Agency.

To View This Article:

Login

Subscribe To Drug Industry Daily